We are excited to announce that our friends at Walgreens have pledged to contribute more than $25 million to Susan G. Komen and The Leukemia & Lymphoma Society to enable research in tough-to-treat cancers and increase access to care, collectively, over the next five years. Through a combination of corporate donations and in-store fundraising, the commitment will enable new research in metastatic breast and pediatric blood cancers, as well as increase access, treatment and support services for those living with these diseases.
Breast cancer and blood cancers are complex to treat and remain prevalent in the United States. Currently, more than 3.8 million people in the U.S. today have been treated for or are living with breast cancer – the most commonly diagnosed cancer in women – and nearly 1.4 million people in the U.S. are living with or in remission from blood cancer.
Donations and funds raised for Susan G. Komen will accelerate the pace of research discovery, particularly as it relates to understanding and combating breast cancer recurrence and metastasis, and will support people facing breast cancer today with trustworthy information and by helping them overcome barriers to timely, high-quality health care.
Walgreens customers can get involved by donating to the organizations during checkout at the more than 9,500 U.S. Walgreens retail pharmacy locations November 3 through 17. The Leukemia & Lymphoma Society and Susan G. Komen are committed to supporting patient services and increasing access to screening and treatments locally and nationally. All donations Walgreens receives in November will be split equally between the two organizations.
Susan G. Komen has a long history of collaborating with Walgreens – nationally and regionally – on a range of local patient assistance initiatives, education efforts, and specialized training for our pharmacists working with cancer patients every day. Most recently, we collaborated on Walgreens’ new Feel More Like You program launch, educating those touched by breast cancer about this new service designed to support those dealing with side-effects of cancer treatment.